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Abstract: A 41-year-old male was admitted to the hospital with symptoms of diarrhea, fever 
and rapidly progressive respiratory distress. A chest radiograph and computed tomography (CT) 
of the chest and the abdomen showed a large amount of right pleural effusion and a large liver 
abscess. The patient was thus diagnosed to have amoebic colitis, amoebic liver abscess and 
amoebic empyema complicated with an HIV infection. The patient demonstrated agranulocytosis 
caused by the administration of trimethoprim-sulfamethoxazole. However, the administration 
of granulocyte colony-stimulating factor made it possible for the patient to successfully recover 
from agranulocytosis, and he thereafter demonstrated a good clinical course.
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Introduction
Recently, the number of newly diagnosed patients with HIV infection is increasing in 
Japan and eastern Asia (even though it is decreasing in most Western countries) while 
amebiasis is also increasing in Japan as a sexually transmitted disease, especially among 
males who admit to having sex with men (MSM). There is also a high frequency of 
asymptomatic Entamoeba histolytica infection, especially among MSM. Amebiasis is 
characterized by diarrhea and it sometimes induces the development of liver abscesses 
as a complication with amebic colitis.1 Pleural empyema is rare as a complication in 
cases of amebiasis. Trimethoprim-sulfamethoxazole is often administered to patients 
with an HIV infection to prevent pneumocystis pneumonia. Unfortunately, trim-
ethoprim-sulfamethoxazole may also induce agranulocytosis in patients with an HIV 
infection, thus leading to the development of severe infectious diseases.
Case report
A 41-year-old male was admitted to the hospital with symptoms of diarrhea, fever, 
dyspnea and right pleural effusion. The illness began in the latter part of August 2008, 
initially presenting with diarrhea and fever. He was an MSM and the serology for HIV 
antibody was positive. He had no history of traveling abroad, alcoholism, any medi-
cation or intravenous drug use. His vital signs on admission were; conscious, blood 
pressure 95/60 mmHg, pulse late 146 beats/min, respiration, 45 breaths/min, saturation 
O2 (room air), 88% and body temperature 39°C. The notable findings of a physical 
examination included emaciation (BMI 16.1), oral candidasis and decreased breath 
sounds on the right side of his chest. A chest radiograph and computed tomography 
(CT) of the chest showed a large amount of right pleural effusion (Figure 1). A CT scan 
of the abdomen detected large liver abscess (Figure 2). The laboratory data included Infection and Drug Resistance 2010:3 
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a leukocyte count of 10,320/µL with 89% neutrophils, 
8% lymphocytes, 3% monocytes, hemoglobin 8.8 g/dL,   
C-reactive protein 23.6 mg/dL, aspirate aminotransfer-
ase 95 U/L, alanine aminotransferase 74 U/L, alkaline 
phosphatase 478 U/L, γ-glutamyl transpeptidase 134 U/L, 
albumin 2.1 g/dL, total cholesterol 57 mg/dL, blood urea 
nitrogen 18.4 mg/dL, creatine 0.57 mg/dL and hyponatremia   
(123 mEq/L). The findings of human immunodeficiency virus 
type 1 antibody tests were positive for enzyme immunoassays 
(EIA) and also based on the Western blot method. Thoracen-
tesis revealed milk chocolate or café au lait colored pleural 
fluid (Figure 3). In an examination of the pleural fluid, 
  cytology, bacterial culture, smear and polymerase chain 
reaction to detect Mycobacterium tuberculosis DNA were 
negative, the adenosine deaminase activity was 240 IU/L. 
The pleural fluid showed a cell count of 40125/mL (74.3% 
neutrocytes, 25.7% monocytes). Other examinations of the 
laboratory findings detected cysts of Entamoeba histolytica 
in the patient’s stool. The CD4 lymphocyte count in the 
peripheral blood was 179/µL (repeated counts for CD4 
lymphocytes ranged from 286 to 359/µL) and the amount 
of HIV-RNA was 3700 copies/µL (repeated counts for HIV-
RNA ranged from 43,000 to 90,000 copies/mL). Although 
E. histolytica was not identified from the pleural fluid, 
  antibodies (fluorescence antibody technique) against   
E. histolytica were demonstrated in the serum (200×). The 
patient was thus diagnosed to have amoebic colitis, amoebic 
liver abscess and amoebic empyema complicated with an 
HIV infection. The right side pleural effusion was drained 
using a chest tube and he was administered metronidazole 
(2250 mg/day) orally for 28 days in total. A large volume of 
pus was drained from the right thoracic space. A small volume 
remained. The right lung was re-expanded. His fever, dyspnea 
and general condition significantly improved thereafter. 
The patient was therefore administered trimethoprim-
sulfamethoxazole to prevent pneumocystis pneumonia 
and itraconazole to prevent fungal infections. However, he 
developed agranulocytosis 22 days after administration. The 
absolute neutrophil count was 0/µL. Agranulocytosis in this 
case was therefore considered to have been caused by the 
administration of trimethoprim-sulfamethoxazole. After 
the discontinuation of trimethoprim-sulfamethoxazole, the 
recombinant human granulocyte colony-stimulating factor 
(G-CSF) drug filgrastim was administered daily at a dose of 
200 µg/m2 intravenously. Following 4 days of treatment with 
G-CSF, the patient’s absolute neutrophil count was above 
9/µL, while after 7 days of treatment it was 2990/µL (white 
blood cell count 4600/µL, neutrophils 65%). The patient 
did not demonstrate any further infection during the clinical 
course. He was discharged 45 days after admission.
Discussion
Amebiasis may become invasive depending on various host 
immune factors, especially in patients with an HIV infection.2 
Three to 9% of patients with amoebic colitis develop amoebic 
liver abscess3 and furthermore 7% to 20% of amoebic liver 
abscess develop amoebic empyema.4,5 However, about a third 
of all cases of pleuropulmonary amebic disease demonstrate 
the presence of exudative or serous, reactive pleural effu-
sion.6,7 This means that some of intrathoracic complications 
Figure  Chest radiography showing complete opacity of the right lung with a shifted 
mediastinum to the left.
Figure  Computed tomography (CT) of the abdomen showing a large liver 
abscess.Infection and Drug Resistance 2010:3 
Amoebic empyema Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
of amebiasis are thus included reactive pleural effusion other 
than amoebic empyema. Some mechanisms of amoebic 
empyema have been previously described. For example, a 
rupture of an amoebic liver abscess into the pleural space 
through the diaphragm, hepatobronchial fistula, lymphatic 
spread, hematogenous spread from the primary intestinal 
lesion have all been reported.6–8 The most common patho-
genetic mechanism of pleural amebic empyema is that 
the liver abscess advances to and across the diaphragm or 
bursts into the right pleural space. In this case, there was no 
hepato-bronchial fistula, no sign of lymphatic spread and no 
perihepatic ascites detected by CT, thus indicating that there 
was no rupture of a liver abscess. Amoebic empyema was 
suggested to occur by extension or inflammatory invasion of 
an amoebic liver abscess directly into the pleural cavity.
The detection of E. histolytica from pleural fluid is rare in 
the diagnosis of amoebic empyema. Amebas are detected in 
less than 10% of cases.5 The diagnosis of amoebic empyema is 
made by the identification of antibodies against E. histolytica 
in the serum, and a negative bacterial culture of the pleural 
fluid. The color of the pus aspirated from amoebic liver 
abscesses also tends to be described as chocolate brown or 
anchovy-sauce color in the literature.6 However, the features 
of amoebic empyema remain to be fully elucidated. The color 
of the pleural fluid in the current case was noteworthy. It was 
different from usual bacterial empyema. Furthermore, the 
pleural fluid in this case did not have a foul odor, although 
most pleural fluid specimens with bacterial empyema tend 
to have a foul odor because the majority of empyema are 
caused by anaerobes. The color and smell of the pleural fluid 
may therefore be a unique diagnostic feature of amoebic 
empyema and may thus be helpful in making a differential 
diagnosis to distinguish common bacterial empyema from 
amoebic empyema.
The administration of trimethoprim-sulfamethoxazole to 
prevent pneumocystis pneumonia is common in the manage-
ment of patients with HIV infection. Therefore, trimethoprim-
sulfamethoxazole was administered after diagnosing the 
patient to have an HIV infection. Agranulocytosis in this case 
was supposed to be due to trimethoprim-sulfamethoxazole. 
Although agranulocytosis is a potentially life-threatening 
condition, especially under conditions of severe amebia-
sis, the patient was able to successfully recover after the 
administration of G-CSF and oral metronidazole. Trim-
ethoprim-sulfamethoxazole is known to sometimes induce 
agranulocytosis as a side effect. As a result, an increasing 
number of such cases are expected in the future because 
many patients with HIV infection require the administra-
tion of trimethoprim-sulfamethoxazole in order to prevent 
pneumocystis pneumonia, and the occurrence of amebiasis 
is also increasing. This case is therefore considered to be an 
instructive case for clinicians.
The management of amoebic empyema in most cases 
involves the administration of parenteral metronidazole,9 
followed by drainage. Metronidazole was administered orally 
in the current patient, followed by drainage, and this yielded 
a good outcome. The incidence of amebiasis is not as high in 
AIDS patients as in HIV-seronegative patients.10
However, whether risk of invasive amebiasis is higher 
among HIV-infected persons than uninfected persons 
remains. Hung and coworkers described persons infected 
with HIV are at an increased risk for invasive amebiasis.2,11 
Furthermore the epidemiology demonstrated that invasive 
amebiasis occurs much more frequently in Taiwan than 
reported in Western countries. Interestingly, amebiasis 
is a relatively common parasitic disease at a time when 
CD4 counts are relatively high in Taiwan in comparison 
to Western countries.2,11 Extraintestinal amebiasis is also 
treated by metronidazole, even in AIDS patients who have 
low CD4 cell counts and receiving anti-HIV drugs.8,11,12 
The estimated mean survival is not significantly different 
between the HIV-infected patients with and without invasive 
amebiasis.11 Even though the population of newly diagnosed 
patients with HIV infection is decreasing in most Western 
countries, the number is, in contrast, increasing in Japan, 
Korea, Hong Kong and Taiwan. In addition, the occurrence 
of invasive amebiasis is therefore also expected to increase 
in these countries.
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